1. OP0250 A randomised, double-blind study to assess the safety, tolerability and preliminary efficacy of leniolisib (CDZ173) in patients with primary sjÖgren's syndrome. (12th June 2018) Authors: Dörner, T.; Zeher, M.; Laessing, U.; Chaperon, F.; De Buck, S.; Hasselberg, A.; Valentin, M.-A.; Ma, S.; Cabanski, M.; Kalis, C.; Burkhart, C.; Gergely, P. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗